Effective with date of service March 15, 2022, the Medicaid and NC Health Choice programs cover naloxone hydrochloride injection for intramuscular or subcutaneous use.
Effective with date of service March 29, 2022, the Medicaid and NC Health Choice programs cover hepatitis b vaccine (recombinant) injectable suspension.
Effective with date of service Feb. 28, 2022, the Medicaid and NC Health Choice programs cover cabotegravir extended-release injectable suspension, for intramuscular use (Apretude).
Effective April 1, 2022, NC Medicaid coverage for pregnant beneficiaries will extend to the last day of the month in which the 12-month postpartum period ends.